Leader of Baltimore Heroin Distribution Ring Sentenced
On November 30, 2012, the US Attorney’s Office for the District of Maryland reported that Walter Powell of Baltimore was sentenced to 121 months in prison and five years of supervised release for leading a heroin distribution ring.
Physician Charged with Possessing Crack Cocaine
On November 28, 2012, the US Attorney’s Office for the Western District of New York reported that a physician in Youngstown, New York named Daniel C Gillick and a woman, Christine D Guilfoyle, were arrested for possessing crack cocaine.
HeartWare Ventricular Assist System Approved
On November 20, the Food and Drug Administration announced the approval of the HeartWare Assist System that helps support heart function and blood flow for patients who are at the end-stage of heart failure and currently await a transplant.
Chantilly Pain Clinic Owner Receives 180 Months
On November 9, 2012, the US Attorney’s Office for the Eastern District of Virginia announced that Paul Boccone was sentenced to 180 months in prison and three years of supervised release after he illegally gave thousands of customers oxycodone prescriptions and other prescriptions as well.
Leader of Indianapolis Drug Organization Gets 10 Years
On November 7, 2012, Immigration and Customs Enforcement (ICE) announced that Agustin Lozano was sentenced to 10 years in prison for leading a drug trafficking organization that ran drugs between Mexico and Chicago.
HPV Vaccine may Help Women Infected with HIV
On November 8, 2012, the National Institutes of Health (NIH) announced that HIV-infected women may benefit from the vaccine for human papillomavirus (HPV)—even if they were already exposed to HPV.
Xarelto Approved to Treat and Reduce Blood Clots
On November 2, the Food and Drug Administration (FDA) approved Xarelto (rivaroxaban) to treat deep vein thrombosis (DVT) and pulmonary embolisms (PE), as well as to reduce the risk of DVT and PE after a surgery or treatment.
Two Indicted for Shipping Illegal Meds into US
On November 7, 2012, the Department of Justice reported that two Pakistani nationals were indicted by a federal grand jury in the District of Columbia for operating websites that shipped illegal pharmaceuticals into the United States from Pakistan and the United Kingdom.
Xeljanz Approved for Rheumatoid Arthritis
On November 6, 2012 the Food and Drug Administration announced the approval of Xeljanz (tofacitinib) for the treatment of moderate and severe rheumatoid arthritis in adults who did not respond or were intolerant to methotrexate.
Drug Fails to Prevent Preterm Birth for High Risk Group
On October 17, 2012, the National Institutes of Health (NIH) announced that a progesterone drug used to prevent preterm birth for women with a previous preterm birth was not successful for first-time mothers with a predisposition for preterm births due to a short cervix.
New Studies for Stronger Pneumonia Vaccine
On October 15, 2012, the National Institutes of Health (NIH) announced funding that will help researchers find out if a higher dose of a vaccine for pneumonia can create a stronger immunity for older adults who received similar vaccines in the past.
Bath Salts Trafficking Leader Pleads Guilty
On October 11, 2012, the US Attorney’s Office for the Eastern District of Virginia announced that Matthew Scott Baker of Fairfax, Virginia pled guilty for leading a trafficking organization for methylone—most commonly known as bath salts.
Guide to Finding Drug Lawyer Due to conflicting laws on the state and federal level, drug lawyers are needed to clear up ambiguities involving clients that find themselves accused of violating drug laws.